Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

187

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01FA01	RITUXIREL	BioTech	Rituximab - 100mg/10ml	100mg/10ml	Injectable concentrated solution	L.L
L04AB01	ETANERREL	BioTech	Etanercept - 25mg/0.5ml	25mg/0.5ml	Injectable solution	L.L
L01FG01	BEVACIREL	BioTech	Bevacizumab - 100mg/4ml	100mg/4ml	Injectable solution	L.L
L01FG01	BEVACIREL	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable solution	L.L
L01FD01	TRASTUREL	BioTech	Trastuzumab - 440mg	440mg	Injectable lyophilised powder	L.L
L04AX06	IMNOVID	B	Pomalidomide - 4mg	4mg	Capsule, hard	L.L
L04AA27	SCLEMOD	G	Fingolimod Hydrochloride - 0.5mg	0.5mg	Capsule	L.L
L01EJ01	CELEZON	G	Ruxolitinib - 20mg	20mg	Tablet	L.L
L01EJ01	CELEZON	G	Ruxolitinib - 15mg	15mg	Tablet	L.L
L01EJ01	CELEZON	G	Ruxolitinib - 5mg	5mg	Tablet	L.L
L01BC07	VIDAZA	B	Azacitidine - 100mg	100mg	Injectable lyophilised powder	L.L
L03AB11	PEGASYS	BioTech	Peginterferon alfa-2a - 180mcg/0.5ml	180mcg/0.5ml	Injectable solution	L.L
L01EF01	PAPILLIO	G	Palbociclib - 125mg	125mg	Capsule, hard	L.L
L01EG02	EVEROLIMUS BIOGARAN	G	Everolimus - 10mg	10mg	Tablet	L.L
L01EG02	EVEROLIMUS BIOGARAN	G	Everolimus - 5mg	5mg	Tablet	L.L
L01DB01	CAELYX	B	Doxorubicin HCl pegylated liposomes - 20mg/10ml	20mg/10ml	Injectable concentrated solution	L.L
L01BA04	PEMETREXED NEAPOLIS	G	Pemetrexed (disodium) - 500mg		Injectable powder	L.L
L01EA02	DASATINIB NEAPOLIS	G	Dasatinib - 50mg	50mg	Tablet, film coated	L.L
L01EA02	DASATINIB NEAPOLIS	G	Dasatinib - 70mg	70mg	Tablet, film coated	L.L
L02BX03	ABREMIA	G	Abiraterone acetate - 250mg	250mg	Tablet	L.L
L01EB01	GEFITINIB ARROW	G	Gefitinib - 250mg	250mg	Tablet, coated	L.L
J05AF10	ENTECAVIR ARROW	G	Entecavir - 0.5mg	0.5mg	Tablet, coated	L.L
J05AF10	ENTECAVIR ARROW	G	Entecavir - 1mg	1mg	Tablet, coated	L.L
L01CD04	CABAZITAXEL EVER PHARMA	G	Cabazitaxel - 60mg/6ml	10mg/ml	Injectable concentrate for solution	L.L
L01XG01	BORTEZOMIB NEAPOLIS	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder for solution	L.L
L01EL01	IMBRUVICA	B	Ibrutinib - 420mg	420mg	Tablet, film coated	L.L
L01XX24	ONCASPAR	B	Pegaspargase - 750U/ml	750U/ml	Injectable powder for solution	L.L
L01EX01	SUTENT	B	Sunitinib maleate - 50mg	50mg	Capsule	L.L
L01EX01	SUTENT	B	Sunitinib maleate - 12.5mg	12.5mg	Capsule	L.L
L01EG02	EVEROLIMUS ARROW	G	Everolimus - 10mg	10mg	Tablet	L.L

...

187